From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles.
In: Journal of Medicinal Chemistry, Jg. 61 (2018-12-27), Heft 24, S. 10996-11020
Online
academicJournal
Zugriff:
Titel: |
From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles.
|
---|---|
Autor/in / Beteiligte Person: | Delost, Michael D. ; Smith, David T. ; Anderson, Benton J. ; Njardarson, Jon T. |
Link: | |
Zeitschrift: | Journal of Medicinal Chemistry, Jg. 61 (2018-12-27), Heft 24, S. 10996-11020 |
Veröffentlichung: | 2018 |
Medientyp: | academicJournal |
ISSN: | 0022-2623 (print) |
DOI: | 10.1021/acs.jmedchem.8b00876 |
Sonstiges: |
|